These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19717477)

  • 1. Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?
    Chang KC; Leung CC; Yew WW; Lau TY; Leung WM; Tam CM; Lam HC; Tse PS; Wong MY; Lee SN; Wat KI; Ma YH
    Eur Respir J; 2010 Mar; 35(3):606-13. PubMed ID: 19717477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).
    Barrera CM; Mykietiuk A; Metev H; Nitu MF; Karimjee N; Doreski PA; Mitha I; Tanaseanu CM; Molina JM; Antonovsky Y; Van Rensburg DJ; Rowe BH; Flores-Figueroa J; Rewerska B; Clark K; Keedy K; Sheets A; Scott D; Horwith G; Das AF; Jamieson B; Fernandes P; Oldach D;
    Lancet Infect Dis; 2016 Apr; 16(4):421-30. PubMed ID: 26852726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.
    Portier H; Brambilla C; Garre M; Paganin F; Poubeau P; Zuck P
    Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):367-76. PubMed ID: 15944847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolones in community-acquired pneumonia when tuberculosis is around: an instructive case.
    Grupper M; Potasman I
    Am J Med Sci; 2008 Feb; 335(2):141-4. PubMed ID: 18277123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions.
    Shen GH; Tsao TC; Kao SJ; Lee JJ; Chen YH; Hsieh WC; Hsu GJ; Hsu YT; Huang CT; Lau YJ; Tsao SM; Hsueh PR
    Int J Antimicrob Agents; 2012 Mar; 39(3):201-5. PubMed ID: 22285045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.
    Velayutham BV; Allaudeen IS; Sivaramakrishnan GN; Perumal V; Nair D; Chinnaiyan P; Paramasivam PK; Dhanaraj B; Santhanakrishnan RK; Navaneethapandian GP; Marimuthu MK; Kumar V; Kandasamy C; Dharuman K; Elangovan T; Narasimhan M; Rathinam S; Vadivelu G; Rathinam P; Chockalingam C; Jayabal L; Swaminathan S; Shaheed JM
    Clin Infect Dis; 2014 Nov; 59(10):e142-9. PubMed ID: 25028463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pitfall of Treatment with Tosufloxacin for Pneumonia That Might Be Lung Tuberculosis.
    Fujishima N; Komiya K; Matsunaga N; Usagawa Y; Yamasue M; Hashinaga K; Umeki K; Nureki SI; Ando M; Matsunaga T; Kadota JI
    Intern Med; 2019; 58(2):263-266. PubMed ID: 30643085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxifloxacin plus standard first-line therapy in the treatment of pulmonary tuberculosis: A meta-analysis.
    Chen Z; Liang JQ; Wang JH; Feng SS; Zhang GY
    Tuberculosis (Edinb); 2015 Jul; 95(4):490-6. PubMed ID: 25964137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones.
    Grossman RF; Hsueh PR; Gillespie SH; Blasi F
    Int J Infect Dis; 2014 Jan; 18():14-21. PubMed ID: 24211230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolones may delay the diagnosis of tuberculosis.
    Ang D; Hsu AA; Tan BH
    Singapore Med J; 2006 Sep; 47(9):747-51. PubMed ID: 16924354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omadacycline for Community-Acquired Bacterial Pneumonia.
    Stets R; Popescu M; Gonong JR; Mitha I; Nseir W; Madej A; Kirsch C; Das AF; Garrity-Ryan L; Steenbergen JN; Manley A; Eckburg PB; Tzanis E; McGovern PC; Loh E
    N Engl J Med; 2019 Feb; 380(6):517-527. PubMed ID: 30726692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days.
    Paris R; Confalonieri M; Dal Negro R; Ligia GP; Mos L; Todisco T; Rastelli V; Perna G; Cepparulo M
    J Chemother; 2008 Feb; 20(1):77-86. PubMed ID: 18343748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis.
    Long R; Chong H; Hoeppner V; Shanmuganathan H; Kowalewska-Grochowska K; Shandro C; Manfreda J; Senthilselvan A; Elzainy A; Marrie T
    Clin Infect Dis; 2009 May; 48(10):1354-60. PubMed ID: 19348594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.
    Dooley KE; Golub J; Goes FS; Merz WG; Sterling TR
    Clin Infect Dis; 2002 Jun; 34(12):1607-12. PubMed ID: 12032896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How are we creating fluoroquinolone-resistant tuberculosis?
    Bernardo J; Yew WW
    Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
    [No Abstract]   [Full Text] [Related]  

  • 17. Moxifloxacin Use and Its Association on the Diagnosis of Pulmonary Tuberculosis in An Inner City Emergency Department.
    Rush B; Wormsbecker A; Stenstrom R; Kassen B
    J Emerg Med; 2016 Mar; 50(3):371-5. PubMed ID: 26416134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of chest computed tomography features between pulmonary tuberculosis patients with culture-positive and culture-negative sputum for non-mycobacteria: A retrospective observational study.
    Kan T; Komiya K; Yamasue M; Itai M; Tanaka A; Takeno Y; Takikawa S; Hiramatsu K; Kadota JI
    Medicine (Baltimore); 2021 Aug; 100(31):e26897. PubMed ID: 34397866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
    Wang JY; Lee CH; Yu MC; Lee MC; Lee LN; Wang JT
    Eur Respir J; 2015 Aug; 46(2):567-70. PubMed ID: 25900374
    [No Abstract]   [Full Text] [Related]  

  • 20. Does radiographic evidence of prior pulmonary tubercular infection influence the choice of empiric antibiotics for community-acquired pneumonia in a tuberculosis-endemic area?
    Jeng YY; Lin YT; Huang LJ; Chen TL; Wang FD; Fung CP; Liu CY
    J Microbiol Immunol Infect; 2010 Oct; 43(5):386-94. PubMed ID: 21075705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.